US Stock MarketDetailed Quotes

IMRX Immuneering

Watchlist
  • 1.500
  • -0.020-1.32%
Close Apr 1 16:00 ET
  • 1.500
  • 0.0000.00%
Post 20:01 ET
53.83MMarket Cap-0.74P/E (TTM)

Immuneering Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
9.69%64.07M
13.84%18.56M
9.68%15.27M
10.43%14.91M
4.98%15.33M
12.54%58.41M
16.56%16.3M
5.45%13.93M
15.50%13.51M
12.14%14.6M
Selling and administrative expenses
-4.07%16.08M
-15.76%3.69M
3.75%4.01M
5.17%4.25M
-6.05%4.12M
7.39%16.76M
6.77%4.39M
0.86%3.87M
9.21%4.05M
10.86%4.38M
-General and administrative expense
-4.07%16.08M
-15.76%3.69M
3.75%4.01M
5.17%4.25M
-6.05%4.12M
7.39%16.76M
6.77%4.39M
0.86%3.87M
9.21%4.05M
10.86%4.38M
Research and development costs
15.23%47.96M
24.74%14.86M
11.97%11.25M
12.69%10.65M
9.71%11.2M
14.77%41.62M
20.65%11.91M
7.33%10.05M
18.44%9.45M
12.72%10.21M
Depreciation amortization depletion
0.00%29.27K
0.00%7.32K
0.00%7.32K
0.00%7.32K
0.00%7.32K
-2.62%29.27K
0.01%7.32K
0.00%7.32K
0.00%7.32K
-9.70%7.32K
-Depreciation and amortization
0.00%29.27K
0.00%7.32K
0.00%7.32K
0.00%7.32K
0.00%7.32K
-2.62%29.27K
0.01%7.32K
0.00%7.32K
0.00%7.32K
-9.70%7.32K
Operating profit
-9.69%-64.07M
-13.84%-18.56M
-9.68%-15.27M
-10.43%-14.91M
-4.98%-15.33M
-12.89%-58.41M
-16.57%-16.3M
-5.60%-13.93M
-15.96%-13.51M
-12.95%-14.6M
Net non-operating interest income expense
-28.10%2.59M
-44.94%415.24K
-36.05%547.07K
-29.15%826.1K
-3.17%804.88K
255.56%3.61M
46.10%754.14K
283.67%855.53K
716.57%1.17M
527.35%831.27K
Non-operating interest income
-28.10%2.59M
-44.94%415.24K
-36.05%547.07K
-29.15%826.1K
-3.17%804.88K
255.56%3.61M
46.10%754.14K
283.67%855.53K
716.57%1.17M
527.35%831.27K
Other net income (expense)
-66.91%441.49K
-80.31%91.43K
-72.81%129.31K
-94.86%7.72K
-12.74%213.04K
515.31%1.33M
107.97%464.35K
293.59%475.6K
724.43%150.19K
336.52%244.13K
Other non- operating income (expenses)
-66.91%441.49K
-80.31%91.43K
-72.81%129.31K
-94.86%7.72K
-12.74%213.04K
515.31%1.33M
107.97%464.35K
293.59%475.6K
724.43%150.19K
336.52%244.13K
Income before tax
-14.15%-61.04M
-19.68%-18.05M
-15.90%-14.6M
-15.51%-14.08M
-5.80%-14.31M
-5.86%-53.47M
-13.87%-15.08M
1.94%-12.6M
-5.74%-12.19M
-4.86%-13.52M
Income tax
Net income
-14.15%-61.04M
-19.68%-18.05M
-15.90%-14.6M
-15.51%-14.08M
-5.80%-14.31M
-5.86%-53.47M
-13.87%-15.08M
1.94%-12.6M
-5.74%-12.19M
-4.86%-13.52M
Net income continuous Operations
-14.15%-61.04M
-19.68%-18.05M
-15.90%-14.6M
-15.51%-14.08M
-5.80%-14.31M
-5.86%-53.47M
-13.87%-15.08M
1.94%-12.6M
-5.74%-12.19M
-4.86%-13.52M
Minority interest income
Net income attributable to the parent company
-14.15%-61.04M
-19.68%-18.05M
-15.90%-14.6M
-15.52%-14.08M
-5.17%-14.31M
-5.86%-53.47M
-13.88%-15.08M
1.94%-12.6M
-5.74%-12.19M
-5.49%-13.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-14.15%-61.04M
-19.68%-18.05M
-15.90%-14.6M
-15.52%-14.08M
-5.17%-14.31M
-5.86%-53.47M
-13.88%-15.08M
1.94%-12.6M
-5.74%-12.19M
-5.49%-13.6M
Basic earnings per share
-8.51%-2.04
-11.54%-0.58
-13.95%-0.49
-9.30%-0.47
3.92%-0.49
1.57%-1.88
-4.00%-0.52
12.24%-0.43
2.27%-0.43
-4.08%-0.51
Diluted earnings per share
-8.51%-2.04
-11.54%-0.58
-13.95%-0.49
-9.30%-0.47
3.92%-0.49
1.57%-1.88
-4.00%-0.52
12.24%-0.43
2.27%-0.43
-4.08%-0.51
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 9.69%64.07M13.84%18.56M9.68%15.27M10.43%14.91M4.98%15.33M12.54%58.41M16.56%16.3M5.45%13.93M15.50%13.51M12.14%14.6M
Selling and administrative expenses -4.07%16.08M-15.76%3.69M3.75%4.01M5.17%4.25M-6.05%4.12M7.39%16.76M6.77%4.39M0.86%3.87M9.21%4.05M10.86%4.38M
-General and administrative expense -4.07%16.08M-15.76%3.69M3.75%4.01M5.17%4.25M-6.05%4.12M7.39%16.76M6.77%4.39M0.86%3.87M9.21%4.05M10.86%4.38M
Research and development costs 15.23%47.96M24.74%14.86M11.97%11.25M12.69%10.65M9.71%11.2M14.77%41.62M20.65%11.91M7.33%10.05M18.44%9.45M12.72%10.21M
Depreciation amortization depletion 0.00%29.27K0.00%7.32K0.00%7.32K0.00%7.32K0.00%7.32K-2.62%29.27K0.01%7.32K0.00%7.32K0.00%7.32K-9.70%7.32K
-Depreciation and amortization 0.00%29.27K0.00%7.32K0.00%7.32K0.00%7.32K0.00%7.32K-2.62%29.27K0.01%7.32K0.00%7.32K0.00%7.32K-9.70%7.32K
Operating profit -9.69%-64.07M-13.84%-18.56M-9.68%-15.27M-10.43%-14.91M-4.98%-15.33M-12.89%-58.41M-16.57%-16.3M-5.60%-13.93M-15.96%-13.51M-12.95%-14.6M
Net non-operating interest income expense -28.10%2.59M-44.94%415.24K-36.05%547.07K-29.15%826.1K-3.17%804.88K255.56%3.61M46.10%754.14K283.67%855.53K716.57%1.17M527.35%831.27K
Non-operating interest income -28.10%2.59M-44.94%415.24K-36.05%547.07K-29.15%826.1K-3.17%804.88K255.56%3.61M46.10%754.14K283.67%855.53K716.57%1.17M527.35%831.27K
Other net income (expense) -66.91%441.49K-80.31%91.43K-72.81%129.31K-94.86%7.72K-12.74%213.04K515.31%1.33M107.97%464.35K293.59%475.6K724.43%150.19K336.52%244.13K
Other non- operating income (expenses) -66.91%441.49K-80.31%91.43K-72.81%129.31K-94.86%7.72K-12.74%213.04K515.31%1.33M107.97%464.35K293.59%475.6K724.43%150.19K336.52%244.13K
Income before tax -14.15%-61.04M-19.68%-18.05M-15.90%-14.6M-15.51%-14.08M-5.80%-14.31M-5.86%-53.47M-13.87%-15.08M1.94%-12.6M-5.74%-12.19M-4.86%-13.52M
Income tax
Net income -14.15%-61.04M-19.68%-18.05M-15.90%-14.6M-15.51%-14.08M-5.80%-14.31M-5.86%-53.47M-13.87%-15.08M1.94%-12.6M-5.74%-12.19M-4.86%-13.52M
Net income continuous Operations -14.15%-61.04M-19.68%-18.05M-15.90%-14.6M-15.51%-14.08M-5.80%-14.31M-5.86%-53.47M-13.87%-15.08M1.94%-12.6M-5.74%-12.19M-4.86%-13.52M
Minority interest income
Net income attributable to the parent company -14.15%-61.04M-19.68%-18.05M-15.90%-14.6M-15.52%-14.08M-5.17%-14.31M-5.86%-53.47M-13.88%-15.08M1.94%-12.6M-5.74%-12.19M-5.49%-13.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -14.15%-61.04M-19.68%-18.05M-15.90%-14.6M-15.52%-14.08M-5.17%-14.31M-5.86%-53.47M-13.88%-15.08M1.94%-12.6M-5.74%-12.19M-5.49%-13.6M
Basic earnings per share -8.51%-2.04-11.54%-0.58-13.95%-0.49-9.30%-0.473.92%-0.491.57%-1.88-4.00%-0.5212.24%-0.432.27%-0.43-4.08%-0.51
Diluted earnings per share -8.51%-2.04-11.54%-0.58-13.95%-0.49-9.30%-0.473.92%-0.491.57%-1.88-4.00%-0.5212.24%-0.432.27%-0.43-4.08%-0.51
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes------------------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Sample Name
Sample Code
 +29.96%
Sample Name
Sample Code
 +24.59%
Sample Name
Sample Code
 +20.05%
4
Tibet Duo Rui Pharmaceutical
301075
+20.02%
5
Chengda Pharmaceuticals
301201
+20.01%
Unlock Now

Discussing

Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 268.460
Sample Name
Sample Code
 382.190
Sample Name
Sample Code
 158.880
4
Meta Platforms
META
586.000
5
NVIDIA
NVDA
110.150
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 13.320
Sample Name
Sample Code
 7.560
Sample Name
Sample Code
 6.640
4
Cipher Mining
CIFR
2.460
5
Hive Blockchain
HIVE
1.540
Unlock Now

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -